Mark E Cartwright

Title: Mark E Cartwright: Innovator in Neurokinin Receptor Antagonists

Introduction

Mark E Cartwright is a notable inventor based in Sparta, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of androgen-dependent diseases. His innovative approach focuses on the use of neurokinin receptor antagonists, which has the potential to improve the quality of life for many patients.

Latest Patents

Mark E Cartwright holds a patent for the "Use of neurokinin receptor antagonists to treat androgen-dependent diseases." This patent details the use of antagonists selected from a specific group of neurokinin receptors to treat symptoms and disorders associated with the production and secretion of androgens. The invention aims to suppress the production and secretion of androgens in mammals suffering from conditions such as benign prostatic hyperplasia and prostatic carcinoma. He has 1 patent to his name.

Career Highlights

Throughout his career, Mark has worked with Schering Corporation, where he has been able to apply his expertise in pharmacology and receptor biology. His work has contributed to advancements in therapeutic strategies for managing androgen-dependent diseases.

Collaborations

Mark E Cartwright has collaborated with notable colleagues, including Elmer J Mirro and Michael W Leach. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mark E Cartwright's contributions to the field of medicine through his patent on neurokinin receptor antagonists highlight his commitment to improving patient care. His work continues to inspire future innovations in the treatment of androgen-dependent diseases.